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Background and aim: This study tested the hypothesis that obesity suppresses circulating number as well as the
function of endothelial progenitor cells (EPCs) and left ventricular ejection fraction (LVEF).
Methods: High fat diet (45 Kcal% fat) was given to 8-week-old C57BL/6 J mice (n = 8) for 20 weeks to induce
obesity (group 1). Another age-matched group (n = 8) were fed with control diet for 20 weeks as controls (group 2).
The animals were sacrificed at the end of 20 weeks after obesity induction.
Results: By the end of study period, the heart weight, body weight, abdominal fat weight, serum levels of total
cholesterol and fasting blood sugar were remarkably higher in group 1 than in group 2 (all p<0.01). The circulating
level of EPCs (C-kit/CD31, Sca-1/KDR, CXCR4/CD34) was significantly lower in group 1 than in group 2 (p<0.03) at
18 h after critical limb ischemia induction. The angiogenesis and migratory ability of bone marrow-derived EPCs
was remarkably impaired in group 1 compared to that in group 2 (all p<0.01). The repair ability of aortic
endothelium damage by lipopolysaccharide was notably attenuated in group 1 compared with that in group 2
(p<0.01). Collagen deposition (Sirius red staining) and fibrotic area (Masson's Trichrome staining) in LV myocardium
were notably increased in group 1 compared with group 2 (p<0.001). LVEF was notably lower, whereas LV end-
diastolic and end-systolic dimensions were remarkably higher in group 1 than in group 2 (all p<0.001).
Conclusions: Obesity diminished circulating EPC level, impaired the recovery of damaged endothelium, suppressed
EPC angiogenesis ability and LVEF, and increased LV remodeling.
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Substantial evidence has shown that obesity is commonly
associated with a broad range of cardiovascular diseases
(CVD), including chronic inflammation, lipid metabolic dis-
order, accelerated atherosclerosis, increased risk for throm-
bosis, hypertension, hyperinsulinemia, insulin resistance,
and type 2 diabetes mellitus [1-6]. Epidemiological study
has further demonstrated that patients with obesity are
twice as likely to die of ischemic heart disease compared to* Correspondence: han.gung@msa.hinet.net
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reproduction in any medium, provided the orthose without obesity [7,8]. Indeed, previous studies have
identified obesity as an important independent risk factor
for cardiovascular events [9-12].
Vascular wall (VW) remodeling from endothelial dys-
function, smooth muscle migration and proliferation,
medial-layer thickening, and decreased number of circu-
lating EPCs and VW- resident EPCs in vasa vasorum/
adventitia is essential in the development of all stages of
atherosclerosis, from initiation, progression, and finally
evolvement of complications [13-17]. An association be-
tween accumulated CVD risk factors and decreased cir-
culating EPC number [18-21] has been extensively
investigated. Additionally, EPCs have been well docu-
mented to play an essential role in repairing endothelial
function and preventing atherosclerosis [22,23].
Interestingly, while the association between the mani-
festation of CVD risk factors and decreased circulating. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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whether obesity itself is an independent factor affecting
the number of circulating EPCs is still unclear. More-
over, the impact of obesity on the function of bone
marrow-derived (BMD) EPCs has not been studied. Fur-
thermore, of particular significance in translational re-
search is whether obesity suppresses the ability of
angiogenesis and vascular repair in response to ischemic
stimulation and toxin-induced vascular endothelial dam-
age, respectively.
Therefore, by using a high fat diet-induced murine
obesity model, this study aimed at testing the hypotheses
that obesity: 1) reduces the number of circulating EPCs,
2) impairs the angiogenic ability of BMDEPCs, 3) hin-
ders the repair of damaged aortic endothelial cells, 4)
suppresses left ventricular ejection fraction (LVEF), and
5) aggravates LV remodeling.
Materials and methods
Ethics
All animal experimental procedures were approved by
the Institute of Animal Care and Use Committee at our
institute and performed in accordance with the Guide
for the Care and Use of Laboratory Animals (NIH publi-
cation No. 85–23, National Academy Press, Washington,
DC, USA, revised 1996).
Animal model of obesity
Eight-week-old male C57J/BL6 mice (n = 18), weighing
22–26 gm, (Charles River Technology, BioLASCO
Taiwan Co., Ltd., Taiwan), were fed with high fat diet (45
Kcal% fat; Research Diets, Inc) to obtain the diet-
induced obesity model for this study. According to the
literature [24] and the instructions from the company
(Research Diets, Inc), successful obesity induction in
mice was defined as an increase in body weight more
than 35% after feeding the animals with high fat diet
(45 Kcal% fat) for 13–14 weeks. Therefore, obese mice
20–22 weeks old were utilized for the purpose of this
study. By the end of 12 weeks, 18 of 24 mice were
observed to fit the criteria of obesity. To determine
whether cardiovascular disease develops after prolonged
feeding with high fat diet, the 18 obese mice were con-
tinuously fed with high fat diet for two additional months
(Group 1). For the purpose of the study, another group
of aged-matched C57J/BL6 mice (n = 18) purchased from
the same company was fed with a control diet for the
same period to serve as normal controls (Group 2).
Animal model of critical limb ischemia for stimulating EPC
mobilization into circulation
Mice in groups 1 and 2 were anesthetized by inhalation
of 2.0% isoflurane. The mice were placed in a supine
position on a warming pad at 37°C with the left hindlimbs shaved. Under sterile conditions, the left femoral
artery, small arterioles, and circumferential femoral ar-
tery were exposed and ligated over their proximal and
distal portions before removal. To avoid the presence of
collateral circulation, the branches were removed to-
gether. Blood was drawn for measuring EPCs using flow
cytometry before being sacrificed at 18 h after CLI
induction.
Functional assessment by echocardiography
Transthoracic echocardiography was performed in all
animals by a cardiologist blinded to the design of the
experiment using a sonographic machine for research
purpose (VisualSonics, Vevo, 2100) at the beginning
and end of the study with the mice under anesthesia
in a supine position. M-mode tracings of left ventricle
(LV) were obtained with the heart being imaged in a
2-dimensional mode in long-axis at the level between
papillary muscle and mitral valve. Left ventricular in-
ternal dimensions [end-systolic diameter (ESD) and
end-diastolic diameter (EDD)] were measured accord-
ing to the American Society of Echocardiography
leading-edge method using at least three consecutives
cardiac cycles. LVEF was calculated as follows:
LVEF %ð Þ ¼ LVEDD3  LVEDS3 =LVEDD3  100.
Protocol and assessment of lipopolysaccharide-damaged
aortic endothelial cells
This study was designed not only to test the number
and function of EPCs, but it also assessed the effect of
lipopolysaccharide (LPS) on the severity of aortic endo-
thelial damage and vaso-relaxation impairment in obese
and control mice. For this purpose, six mice from each
group were randomly chosen to receive LPS treatment.
To elucidate the safety and optimal dosage of LPS for
inducing aortic endothelial damage, three dosages of
LPS (i.e. 1, 2, and 3 μM intra-peritoneal injection) were
given to two mice in each group (i.e. obese and control
group). While the highest dosage (3.0 μM) caused mor-
tality, only the moderate dosage was found to cause a
significant difference of EPC number in the aortic in-
timal layer between the two groups of survivors. The
moderate dosage of LPS, therefore, was used in the
current study.
Flow cytometric quantification of endothelial progenitor
cells
For blood sampling at different time points (i.e. prior to
CLI and at 18 h and on day 14 after induction of CLI),
cardiac puncture instead of the venous route was
adopted for blood sampling using a 30# needle. After
treatment with red blood cell-lysing buffer, the cells
remained were labeled with appropriate antibodies. Flow
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kers was performed based on our recent reports [25].
Briefly, the cells were immunostained for 30 minutes
with PE-conjugated antibodies against CD31 (BioLe-
gend), KDR (BD Pharmingen), CD34 (BD Pharmingen)
and FITC-conjugated antibodies against Sca-1 (BD
Pharmingen), c-Kit (BD Pharmingen), CXCR4 (BD
Pharmingen). Isotype-identical antibodies (IgG) served
as controls. Flow cytometric analyses were performed by
utilizing a fluorescence-activated cell sorter (Beckman
Coulter FC500 flow cytometer).
Bone marrow mononuclear cell culture, differentiation
of endothelial cell phenotype, angiogenesis, and meas-
urement of total tubular length
To evaluate the degree of angiogenesis, bone marrow
was drawn from both obese and control animals. The
protocol and procedure of cell culture and the determin-
ation of angiogenesis were described in our recent report
[26]. Briefly, MNCs were isolated by density-gradient
centrifugation of Ficoll 400, followed by cultivation in
differential endothelial cell culture medium (endothelial
cell basal medium-2, Cambrex) with 10% fetal bovine
serum (FBS), 50 U/mL penicillin, 50 μg/mL strepto-
mycin and 2 mmol/L L-glutamine (Invitrogen) with vas-
cular endothelial growth factor (VEGF) and basic
fibroblast growth factor (10 ng/mL) plated on gelatin-
coated tissue culture flasks and incubated at 37°C with
5% CO2 for 21 days. Culture medium was changed every
48 hours. By day 21, cells with spindle-shaped and
cobblestone-like phenotype typical of endothelial cells
were found attached on the plate.
The cells with endothelial cell phenotype were then
plated in 96-well plates at 1.0 × 104 cells/well in 150 μL
serum-free M199 culture medium mixed with 50 μL
cold Matrigel (Chemicon international) for 24 hours
using passage 2 EPCs incubated at 37°C in 5% CO2.
Three random microscopic images (200 ×) were taken
from each well for counting cluster, tube, and network
formations with the mean values obtained. Both cumula-
tive and mean tube lengths were calculated by Image-
Pro Plus software (Media Cybernetics).
Transwell migratory assay
To investigate the transwell migratory ability of EPCs
(n = 6 in each experiment), transwell membranes (5 μm;
Costar, Germany) were coated on both sides with fibro-
nectin (2.5 μg/mL; Roche, Mannheim, Germany) over-
night at 4 °C. The experimental protocol was also based
on that of our recent report [26]. EPCs (1 × 105 cells/
well) were resuspended in M199 medium (Gibco, Carls-
bad, CA, USA) containing 0.5 FBS (Gibco, Carlsbad,
CA, USA) and incubated in the upper chamber at 37°C
in 5% CO2 and allowed to migrate for 18 hours toward
the lower chamber which was filled with M199containing 20% FBS. Cells remaining on the upper sur-
face of the transwell membranes were mechanically
removed and cells that had migrated to the lower surface
were fixed with 4% formaldehyde. For cell quantification,
nuclei of the migrated cells were stained with DAPI.
Cells migrating into the lower chamber were counted
over 5 random microscopic fields using a fluorescence
microscope (Olympus, Tokyo, Japan) with the software
Image-Pro Plus (Media Cybernetics, Bethesda, MD,
USA).
Immunofluorescent (IF) staining
To determine the number of EPCs localized in the endo-
thelial and adventitia (i.e. around the vasa vasorum)
layer, IF staining was performed for the examinations of
C-kit+, CD34+, Flk-1+ cells (n = 6 for each group) using
respective primary antibodies as we previously reported
[27]. Irrelevant antibodies were used as controls in the
present study.
Immunohistochemical (IHC) staining
To analyze the extent of collagen synthesis and depos-
ition, three cardiac paraffin sections (6 μm) at 3 mm
intervals were stained with picro-Sirius red (1% Sirius
red in saturated picric acid solution) for one hour at
room temperature using standard methods. The sections
were then washed twice with 0.5% acetic acid. The water
was physically removed from the slides by vigorous
shaking. After dehydration in 100% ethanol thrice, the
sections were cleaned with xylene and mounted in a res-
inous medium. High-power fields (×100) of each section
were used to identify Sirius red-positive area on each
section. Image-pro plus 6.1 software (Media Cybernetics,
Inc., Bethesda, MD, USA) was used to calculate the total
area of Sirius red-positive staining. The mean area of
collagen deposition was obtained by summation of Sirius
red-positive areas on each section divided by the total
numbers of sections.
Histological study of fibrosis area in LV
Masson's Trichrome staining was used for studying fi-
brosis of LV myocardium. The integrated area (μm2) of
fibrosis in LV myocardium in the tissue sections was cal-
culated using Image Tool 3 (IT3) image analysis software
(University of Texas, Health Science Center, San Anto-
nio, UTHSCSA; Image Tool for Windows, Version 3.0,
USA) as described previously [27]. Three selected sec-
tions were quantified for each animal. Three randomly
selected high-power fields (HPFs) (400 ×) were analyzed
in each section. After determining the number of pixels
in each fibrosis area per HPF, the numbers of pixels
obtained from the three HPFs were summated. The pro-
cedure was repeated in two other sections for each ani-
mal. The mean pixel number per HPF for each animal
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and dividing by 9. The mean area of fibrosis per HPF
was obtained using a conversion factor of 19.24 (1 μm2
represented 19.24 pixels).
Measurement of aortic contractility and nitric oxide
release on LPS overload
At the end of the study, six mice in each group were
treated by LPS. Forty-eight hours after LPS treatment,
the mice were sacrificed and the aorta in each mouse
was isolated. Aortic segments in each mouse were col-
lected for identification of EPCs localized in aortic endo-
thelial layer using IHC staining. Other aortic segments
were cleaned and cut into slices of 2 mm in length for
evaluating the contractile and relaxant response as previ-
ously reported [28] with some modifications. Briefly, the
aortic rings were carefully mounted on an isometric
force transducer (XDFT05, Singa, Taiwan) with a tension
of 1.8 g and placed in an organ chamber filled with
Krebs solution (NaCl, 99.01 mM; KCl, 4.69 mM; CaCl2,
1.87 mM; MgSO4, 1.20 mM; K2HPO4, 1.03 mM; glucose,
11.1 mM) maintained at pH 7.4 and bubbled with 95%
O2 - 5% CO2. After an equilibration of 40 minutes,
1 μM of phenylephrine (PE) was added to the organ
chamber for the assessment of contractile activity, and
then 30 μM of acetylcholine (ACh) was added to assess
the endothelial integrity. After washing and a re-
equilibration for 30 minutes, a cumulative PE dose (from
1 nM to 1 μM) was added to the organ chamber to ob-
tain a concentration-dependent contractile curve, and
then sodium nitroprusside (30 μM) was added to the
organ chamber to obtain a relaxant response. After
washing and a re-equilibration for 20 minutes, 30 μM of
ACh was added into the organ chamber, followed by
1 μM of PE to evaluate the endothelium-dependent
vasorelaxant response. Then PE (1 μM)-induced vaso-
contractile response was assessed again in the presence
of L-NAME (100 μM) pre-treatment for 30 minutes. All
data were acquired and analyzed using the XctionView
system (XctionView, Singa, Taiwan).
Protocol for assessment of aortic basal nitric oxide (NO)
release on LPS overload
Vascular basal nitric oxide release was calculated as the
percentage of difference between PE-induced vasocon-
tractile response in the absence and presence of L-
NAME according to our previous study [28].
Statistical analysis
Quantitative data are expressed as means ± SD. Statis-
tical analysis was adequately performed by ANOVA
followed by Tukey’s multiple comparison procedure.
Statistical analysis was performed using SAS statistical
software for Windows version 8.2 (SAS institute, Cary,NC). A probability value <0.05 was considered statisti-
cally significant.
Results
Baseline characteristics, laboratory findings, and
transthoracic echocardiography results
The initial body weight (BW) did not differ between the
obese (group 1) and control (group 2) animals. However,
the final BW was significantly higher in group 1 than in
group 2. Neither the heart weight nor the ratio of heart
weight to tibial bone length was different between the
two groups. Additionally, the initial blood sugar did not
differ between group 1 and group 2. However, the ab-
dominal fat weight, serum levels of total cholesterol and
final blood sugar were notably higher in group 1 than in
group 2 (Table 1).The initial LVEF, fractional shortening
(FS), LVEDd, LVESd and the thickness of interventricu-
lar septum and posterior wall did not differ between
groups 1 and 2. Moreover, at the end of the study, the
thickness of interventricular septum and posterior wall
were similar between groups 1 and 2. However, at the
end of study, LVEF and fractional shortening were sig-
nificantly lower, whereas LVEDd and LVESd were re-
markably higher in group 1 than in group 2 (Table 1).
The initial LVEF, fractional shortening (FS), LVEDd,
LVESd and the thickness of interventricular septum and
posterior wall did not differ between groups 1 and 2.
Moreover, at the end of the study, the thickness of inter-
ventricular septum and posterior wall were similar be-
tween groups 1 and 2. However, at the end of study,
LVEF and fractional shortening were significantly lower,
whereas LVEDd and LVESd were remarkably higher in
group 1 than in group 2.
Circulating level of EPC at baseline and 18 h after critical
limb ischemia (CLI) procedure
Interestingly, at day 0 prior to the procedure, the circu-
lating levels of EPCs (C-kit/CD31, Sca-1/KDR, CXCR4/
CD34) were similar between group 1 and group 2. How-
ever, at 18 h after the CLI procedure, these biomarkers
were notably lower in group 1 than in group 2 (Table 1).
These findings implicate that EPC mobilization from
bone marrow to circulation in response to ischemic
stimuli was markedly impaired in obesity.
IHC and IF staining of aorta
Prior to LPS treatment, IHC staining showed that the
number of patched distribution (diameter ≥ 2.0 μm) of
MMP-9 in medial layer of aorta, an index of inflamma-
tion, was remarkably higher in group 1 than in group 2.
In addition, at 18 hours after LPS treatment, the number
of patched distribution of these biomarkers in the medial
layer of the aorta was remarkably higher in group 1 than
in group 2. On the other hand, the number of patched
Table 1 The baseline characteristics, laboratory findings and echocardiography results
Variables Obesity (n = 8) Control (n = 8) P value*
Initial body weight (g) 25.7 ± 0.66 26.0 ± 0.72 0.448
Final body weight (g) 43.9 ± 1.55 34.4 ± 1.48 <0.0001
Heart weight (g) 0.19 ± 0.02 0.14 ± 0.01 <0.0001
Ratio of heart weight to tibial bone length 0.095 ± 0.002 0.070 ± 0.001 <0.001
Abdominal fat weight (g) 4.09 ± 0.65 1.66 ± 0.41 <0.0001
Total cholesterol (mg/dl) 232.8 ± 7.53 136.3 ± 11.8 <0.01
Initial fasting blood glucose level (mg/dl)† 103 ± 8.63 98.3 ± 9.0 0.657
Final fasting blood glucose level (mg/dl)† 307.5 ± 74.7 142.5 ± 18.3 <0.0001
Circulating level of endothelial progenitor cells
C-kit/CD31 (%)
Baseline (0 h){ 1.15 ± 0.21 1.06 ± 0.40 0.636
18 hour} 2.60 ± 0.49 3.29 ± 0.50 0.025
Sca-1/KDR (%)
Baseline{ 0.85 ± 0.27 0.66 ± 0.21 0.169
18 hour} 1.05 ± 0.24 1.60 ± 0.22 0.042
CXCR4/CD34 (%)
Baseline (0 h){ 0.38 ± 0.17 0.43 ± 0.27 0.745
18 hour} 0.68 ± 0.31 1.13 ± 0.36 0.033
Echocardiograph (baseline)
Inter-ventricular septum (mm) 0.82 ± 0.08 0.83 ± 0.09 0.360
Posterior wall (mm) 0.77 ± 0.11 0.76 ± 0.09 0.601
Left ventricular end-diastolic dimension (mm) 4.10 ± 0.10 3.93 ± 0.26 0.438
Left ventricular end-systolic dimension 2.71 ± 0.21 2.63 ± 0.23 0.588
Fractional shortening (%) 32.7 ± 1.98 34.4 ± 2.01 0.212
Left ventricular ejection fraction (%) 62.5 ± 2.43 64.0 ± 2.49 0.327
Echocardiograph (at end of study period)
Inter-ventricular septum (mm) 0.87 ± 0.06 0.86 ± 0.08 0.949
Posterior wall (mm) 0.79 ± 0.08 0.77 ± 0.03 0.686
Left ventricular end-diastolic dimension (mm) 4.46 ± 0.17b 4.18 ± 0.16a 0.031
Left ventricular end-systolic dimension 3.46 ± 0.48b 2.78 ± 0.13a <0.001
Fractional shortening (%) 22.8 ± 1.15b 33.4 ± 0.85a <0.001
Left ventricular ejection fraction (%) 46.0 ± 1.95b 62.7 ± 1.43a <0.001
Group 1 = obesity.
Group 2 = normal control.
* by t test.
† value was observed after 12 fasting in the mice.
{ blood sample was collected prior to critical limb ischemia procedure.
} blood sample was collected at 18 h after critical limb ischemia procedure.
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group 2 animals with and without LPS treatment
(Figure 1).
The numbers of C-kit + and Sca-1+ cells located in the
intimal layer of aorta were significantly higher group 2
than in group 1 prior to LPS treatment, whereas the
number of Flk-1+ cells in the intimal layer of aorta was
similar between the two groups. However, at 18 h after
LPS treatment, the numbers of cells positive for thesebiomarkers in the intimal layer of aorta were substan-
tially higher in group 2 than in group 1 (Figure 2, 3 &
4). These findings implicate that obesity impairs the abil-
ity of recovery after endotoxin-induced damage of endo-
thelial cells.
Satining of left ventricular myocardium
Hematoxylin and eosin (H & E) staining revealed no
evidence of atherosclerotic obstructive coronary artery
Figure 1 Immunohistochemical (IHC) staining (400x) for the cluster formation (≥ 2.0 μm) of matrix metalloproteinase (MMP)-9 in
medial layer of aorta (n = 6). E) Showing the cluster formation of MMP-9 (black arrows) was significantly higher in obesity (B) than in normal
control (A) prior to lipopolysaccharide (LPS) treatment, more significantly higher in obesity (D) than in normal control (C) after LPS treatment.
Statistical analysis by one-way ANOVA. * vs. † vs. { vs. }, p < 0.0001. Symbols (*, †, {, }) indicate significant difference (at 0.05 level) followed by
Bonferroni’s multiple-comparisons post hoc test. L = lumen side. Scale bars in upper or lower corner represent 20 μm. HPF= high-power field.
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5-A to 5-F). However, the number of vasa vasorum
(Figure 5-G) and EPCs [CD34+ (Figure 5-H), Flk-1+
(Figure 5-I), Sca-1+ (Figur 5-J)] around vasa vasorum/
adventia of large epicardial vessels were remarkably
reduced in group 1 as compared with group 2.
Sirius red staining for collagen deposition and Masson's
trichrome staining for fibrosis in left ventricular
myocardium
Sirius red staining (Figure 6-A & 6-B) demonstrated that
collagen fiber deposition in LV myocardium wasFigure 2 IHC staining (400x) for number of C-kit + stained cells in end
C-kit + stained cells (black arrows) was significantly higher in normal contro
higher in normal control (C) than in obesity (D) after LPS treatment. Statisti
(*, †, {, }) indicate significant difference (at 0.05 level) followed by Bonferro
left lower corner represent 20 μm. HPF= high-power field.remarkably higher in group 1 than in group 2 (Figure 6-
C). In addition, Masson's Trichrome staining (Figure 6-
D & 6-E) revealed that the distribution of fibrosis was
markedly increased in group 1 animals compared to that
in group 2 (Figure 6-F).
Aortic vasorelaxation and NO release
Baseline NO release from endothelial cells of aorta was
significantly enhanced in group 1 compared to that in
group 2. Moreover, after LPS-induced endothelial dam-
age, the NO-releasing ability was remarkably impaired in
both groups, particularly in group 2 (Figure 7-A). Theseothelial layer of aorta (n = 6). E) Demonstrating the number of
l (A) than in obesity (B) prior to LPS treatment, more significantly
cal analysis by one-way ANOVA. * vs. † vs. { vs. }, p < 0.0001. Symbols
ni’s multiple-comparisons post hoc test. L = lumen side. Scale bars in
Figure 3 IHC staining (400x) for number of Sca-1+ stained cells in endothelial layer of aorta (n = 6). E) Demonstrating the number of Sca-
1+ stained cells (black arrows) was significantly higher in normal control (A) than in obesity (B) prior to LPS treatment, more remarkably higher in
normal control (C) than in obesity (D) after LPS treatment. Statistical analysis by one-way ANOVA. * vs. † vs. { vs. }, p < 0.0001. Symbols (*, †, {, })
indicate significant difference (at 0.05 level) followed by Bonferroni’s multiple-comparisons post hoc test. L = lumen side. Scale bars in lower or
upper corner represent 20 μm. HPF= high-power field.
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occur in obese mice to maintain vasorelaxation at both
baseline and in situation of LPS-induced endothelial
damage.
Baseline KCl-induced vasoconstriction did not differ in
obesity as compared with normal control regardless with
and without LPS treatment (Figure 7-B). Baseline PE-
induced vasoconstriction was notably reduced in group
1 compared to that in group 2. Besides, after LPS treat-
ment, the responsibility of PE-induced vasoconstriction
was weaker in group 1 than in group 2. By contrast,
ACh-induced vasorelaxation exhibited an oppositeFigure 4 IHC staining (400x) for number of Flk-1+ stained cells in end
+ stained cells (black arrows) was similar between normal control (A) and o
biomarker in endothelial layer of aorta was significantly higher in normal c
one-way ANOVA. * vs. † vs. {, p < 0.0001. Symbols (*, †, {) indicate significa
comparisons post hoc test. L = lumen side. Scale bars in left lower corner remanner compared to that of PE-induced vasoconstric-
tion in baseline condition and after LPS treatment in
both groups of animals (Figure 7-C & 7-D). The results
indicate that the VW of obese mice was in a hyper-
reactive state toward both vasodilatation and vasocon-
strictive stimuli.
In vitro studies for measurement of total tubular length,
transwell migratory assay, and proliferation assessment
To compare the angiogenesis ability and function of
EPC between obesity and normal mice, BMDMNC cul-
ture for EPC was performed. Interestingly, the resultsothelial layer of aorta (n = 6). E) Demonstrating the number of Flk-1
besity (B) prior to LPS treatment. However, the number of this
ontrol (C) than in obesity (D) after LPS treatment. Statistical analysis by
nt difference (at 0.05 level) followed by Bonferroni’s multiple-
present 20 μm. HPF= high-power field.
Figure 5 IHC staining (400x) for number of the vasa vasorum and numbers of CD34+, Flk-1+, Sca-1+ cells in left ventricular
myocardium (n = 8). G) The number of vasa vasorum (red arrows) was remarkably higher in normal control than in obesity. * vs. normal,
p < 0.0001. H) The number of CD34+ stain cells (yellow arrows) was significantly higher in normal control (A) than in obesity (B). * vs. normal,
p < 0.001. I) The number of Flk-1+ cells (green arrows) was notably higher in normal control (C) than in obesity (D). * vs. normal, p < 0.001. J) The
number of Sca-1+ cells (pink arrows) was notably higher in normal control (E) than in obesity (F). * vs. normal, p < 0.001. MA, MB, MC, MD, MA, and
MAF indicated dotted line area (i.e., the vasa vasorum) was magnified for 1000x. Scale bars in left lower corner represent 20 μm.
Tsai et al. Journal of Translational Medicine 2012, 10:137 Page 8 of 12
http://www.translational-medicine.com/content/10/1/137showed that cluster formation (p < 0.001), tubular forma-
tion (p < 0.0001), and network formation (p < 0.0001)
were remarkably lower in obese mice than in control
mice (Figure 8-A to 8-F). In addition, the accumulative
tubular length (P < 0.0001) was also notably reduced in
obese mice. Furthermore, the number of transwell mi-
gratory EPCs (Figure 8-I & 8-J ) was substantially lowerFigure 6 Sirius red stain and Masson's Trichrome Stain of left ventricu
(100x) demonstrated that the collagen-fiber deposition area (yellow-dot lin
normal control (A). F) The results of Masson's trichrome staining (100x) sho
control (D). * vs. normal, p < 0.0001. Scale bars in left lower corner represenin obese mice compared to that in control mice
(p<0.0001).
Discussion
This study, which investigated the impact of obesity on
cardiovascular pathogenesis in a murine obesity model,
yielded several striking implications. First, repair ability oflar (LV) myocardium (n = 8). C) The results of Sirius red staining
es) in LV myocardium was significantly higher in obesity (B) than in
wed significantly higher fibrotic area in obesity (E) than in normal
t 100 μm. HPF= high-power field.
Figure 7 Aortic vasorelaxation and nitric oxide (NO) release (n = 6). A) NO release from endothelial cells of aorta was significantly higher in
obesity than in normal control prior to LPS treatment. NO-release was remarkably impaired in obesity and more remarkably impaired in normal
control after LPS treatment. * vs. † vs. { vs. }, p < 0.0001. B) the KCl-induced vasoconstriction did not differ in obesity as compared with normal
control regardless with and without LPS treatment. C) Phenylephrine (PE)-induced vasoconstriction was notably reduced in obesity as compared
with normal control prior to LPS treatment (p < 0.01). Additionally, after the LPS treatment, the responsibility of PE-induced vasoconstriction was
more prominent in normal control than in obesity (p < 0.001). D) Ach-induced vasorelaxation was significantly lower in normal control than in
obesity prior to LPS treatment and more significantly lower in normal control than in obesity after LPS treatment (all p values < 0.001). * vs. † vs. {
vs. }, p < 0.0001. Symbols (*, †, {, }) indicate significant difference (at 0.05 level) followed by Bonferroni’s multiple-comparisons post hoc test.
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http://www.translational-medicine.com/content/10/1/137EPC in response to LPS-induced damage of aortic endo-
thelium was remarkably impaired in obese animals. Sec-
ond, the circulating level of EPCs in the setting of CLI was
significantly reduced in obese mice compared to that in
normal mice. Third, LV remodeling was markedly
increased, whereas LV function was notably suppressed in
obese mice compared with the normal control animals.
Fourth, hyper-reactive vasorelaxation and over compensa-
tory NO production from aorta was observed in the obese
animals. Finally, the number of EPCs and vasa vasorum in
adventitia layer of epicardial arteries was significantly
reduced in the setting of obesity.
In the present study, not only does the entire body
weight increase, but also heart weight, ratio of heart
weight to tibial length, abdominal fat weight, and total
cholesterol level were substantially higher in obese ani-
mals than those in control animals. These findings sug-
gest that the high-fat diet induced a successful obesity
model in mice. One important finding is that feeding
with high-fat diet also induced hyperglycemia.
Clinical observational studies have previously shown
that the circulating number of EPCs was significantly
decreased in manifestation of CVD risk factors and the
presence of coronary artery disease (CAD) [18-21].Interestingly, in the present study, histological analysis
of the LV sections with α-SMA staining showed no evi-
dence of atherosclerotic obstructive CAD in obese mice.
Additionally, the baseline circulating levels of EPC were
similar between obese and normal control mice. Our
results, therefore, in addition to supporting the findings
of previous studies [18-21], also provide useful informa-
tion that the circulating number of EPCs may be normal
in the setting of obesity without manifestation of athero-
sclerotic obstructive CAD.
The link between obesity and endothelial and vascular
dysfunction has been extensively discussed recently
[29,30]. An essential finding in the current study is that,
as compared with the normal controls, an increase in
the circulating number of EPCs in response to ischemic
stress was remarkably suppressed in obese mice. This
finding indicates that the EPC mobilization ability from
bone marrow to circulation in response to ischemic
stimulation is curtailed in obesity. Moreover, aortic
endothelial repair ability after LPS-induced endothelial
damage was found to be notably reduced in obese ani-
mals. Furthermore, Matrigel assay demonstrated that the
angiogenesis ability, an index of endothelial function,
was substantially suppressed in the setting of obesity.
Figure 8 Angiogenesis and migratory assay (n = 6). Illustration (100x) of angiogenesis in normal control (A) and obesity (B). The network
(blue-dot lone) (C), cluster (red arrow) (D) and tubular (white arrows) (G) formation and tubular length (H), indexes of angiogenesis, were
significantly increased in normal control than in obesity. E & F) Human umbilical vein endothelial cells (HUVECs) were utilized for formation of
angiogenesis platform (100×). The same number of EPCs (1.0 × 103) (DAPI positively stained cells) from normal control and obesity mice were co-
cultured with HUVECs (2.0 × 103) in Matrigel for 24 h. The results showed notably higher number of EPCs and cluster formation (black arrow)
within the HUVEC-formed angiogenic platform in normal than in obesity. Scale bar in right lower corner represent 100 μm. I & J) Illustration of
migratory assay (400×). The blue color represented the nuclei were stained with DAPI. Scale bar in right lower corner represent 20 μm. K)
Showing the numbers of migratory EPCs in Transwell, an index of EPC kinesis, were significantly higher in normal control than in obesity. For (D),
* vs. normal, p < 0.001; For (C), (G), (H) and (K), * vs. normal, p < 0.0001.
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gratory ability was significantly hindered in obese ani-
mals compared to that in their normal counterparts.
These findings highlight the fact that EPC/endothelial
function (i.e., angiogenesis, EPC kinetics) rather than
EPC number is reduced before the manifestation of ob-
structive CAD. In this way, our findings reinforce those
of previous clinical observational studies [29,30].
Although the role of obesity in impairing LV function
and increasing LV remodeling have been keenly investi-
gated in previously clinical observational studies, the
study of heart function in animal models of obesity has
seldom been reported [31-33]. The most important find-
ing in this experimental study is that LVEF and FS were
significantly lower in obese mice than those in normal
controls. Of importance is that LV remodeling (i.e.,
increased LVEDd and LVESd) was remarkably increased
in obese animals compared to that in their normal coun-
terparts. Accordingly, the results of the present study
support the findings from previous clinical observational
studies [31-33]. Another principal finding in the current
study using Masson's Trichrome staining showed that
the fibrotic area was substantially increased in obese
mice. Consistently, Sirius red staining revealed signifi-
cantly heavier deposition of collagen fiber in LVmyocardium of obese mice than that of normal controls.
Furthermore, the numbers of vasa vasorum and EPCs
over adventitia of epicardial vessels were significantly
reduced in the former than in the latter animals. These
findings may, at least in part, explain the notable impair-
ment in LV function significant increase in LV remodel-
ing in the obese mice even in the absence of
atherosclerotic obstructive CAD (i.e. α-SMA results of
patent epicardial vessels). Surprisingly, the underlying
mechanisms involved in cardiac remodeling in obese
patients without overt atherosclerosis-related CAD have
not been investigated in previous clinical observational
studies [31-33]. Our results, therefore, further extend
the findings of those studies [31-33].
On the other hand, previous studies have empha-
sized that obesity results in an imbalance between
endothelium-derived vasoactive factors favoring vaso-
constriction and inflammatory activation. Abnormal
regulation of these factors due to endothelial cell dys-
function is both the consequence and cause of vascular
disease processes [34]. Thus, obesity can be considered
to cause accelerated "premature" vascular aging [34].
Interestingly, the results of the present study demon-
strated notably increased baseline NO release from the
aorta in obese mice than that in the normal controls
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aortic endothelial damage was still significantly higher in
the former than in the latter (Figure 7-A). Based on this
finding, we propose that this phenomenon may be due
to 1) a compensatory response to obesity-induced endo-
thelial dysfunction at the early stage in a scenario com-
parable to hyper-insulinemic response in the setting of
early hyperglycemic/diabetes mellitus situation; 2) it may
also be due to a relatively higher intrinsic resistance of
murine aortic endothelial cells against obesity-induced
damage compared to that in the human beings. This sec-
ond hypothesis could be further supported by the find-
ing (Figure 7-B) that KCl-induced vasoconstriction (i.e.
the integrity of calcium channel in smooth muscle cells)
did not differ between obese and normal control mice.
Our findings could further explain the notably lower PE-
induced vasoconstriction (Figure 7-C), but apparently
higher the ACh-induced vasorelaxation (Figure 7-D) in
obese mice than those in normal controls. In this way,
our findings are not completely identical to the those
previously reported [34,35].
Study limitations
This study has limitations. First, the exact underlying
mechanisms involved in the impairment of heart func-
tion were not fully investigated in the current study. Sec-
ond, the effects of therapeutic intervention and statin
treatment on body weight, hypercholesterolemia, heart
function, and circulating level of EPCs were not exam-
ined in the present study.
Conclusions
This study demonstrated that the circulating number
and function of EPCs as well as heart function were
markedly reduced, whereas LV remodeling was signifi-
cantly enhanced in obesity even without overt athero-
sclerotic obstructive CAD.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
All authors have read and approved the final manuscript. YKH, TTH, CHT,
WCJ and SL designed the experiment, drafted and performed animal
experiments. SCK, SS, CYL, CSY, CHW and KSF were responsible for the
laboratory assay and troubleshooting. YKH, WCJ and HKY participated in
refinement of experiment protocol and coordination and helped in drafting
the manuscript. All authors report no disclosures and have any commercial
associations or interests, including consultancies, stock ownership or other
competing equity interest.
Acknowledgements
This study was supported by a program grant from Chang Gung Memorial
Hospital, Chang Gung University (Grant number: CMRPG 890641).
Author details
1Division of Cardiology, Department of Internal Medicine; Chang Gung
Memorial Hospital- Kaohsiung Medical Center, Chang Gung University
College of Medicine, Kaohsiung, Taiwan. 2Department of EmergencyMedicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan. 3Department
of Life Science, National Pingtung University of Science and Technology,
Pingtung, Taiwan. 4Center for translational research in biomedical science,
Chang Gung Memorial Hospital- Kaohsiung Medical Center, Chang Gung
University College of Medicine, Kaohsiung, Taiwan. 5Departments of
Radiology, Chang Gung Memorial Hospital- Kaohsiung Medical Center,
Chang Gung University College of Medicine, Kaohsiung, Taiwan.
6Department of Biological Sciences, National Sun Yat-Sen University
Kaohsiung, Kaohsiung, Taiwan. 7Department of Internal Medicine, Division of
Cardiology, Chang Gung Memorial Hospital, Kaohsiung 123, Ta Pei Road,
Niao Sung Dist, Kaohsiung City 83301, Taiwan.
Received: 25 January 2012 Accepted: 7 June 2012
Published: 2 July 2012
References
1. Goodpaster BH, Krishnaswami S, Harris TB, Katsiaras A, Kritchevsky SB,
Simonsick EM, Nevitt M, Holvoet P, Newman AB: Obesity, regional body fat
distribution, and the metabolic syndrome in older men and women.
Arch Intern Med 2005, 165:777–783.
2. Permana PA, Menge C, Reaven PD: Macrophage-secreted factors induce
adipocyte inflammation and insulin resistance. Biochem Biophys Res
Commun 2006, 341:507–514.
3. Tilg H, Moschen AR: Adipocytokines: mediators linking adipose tissue,
inflammation and immunity. Nat Rev Immunol 2006, 6:772–783.
4. Chen H: Cellular inflammatory responses: novel insights for obesity and
insulin resistance. Pharmacol Res 2006, 53:469–477.
5. Delarue J, Magnan C: Free fatty acids and insulin resistance. Curr Opin Clin
Nutr Metab Care 2007, 10:142–148.
6. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM,
Fava F, Tuohy KM, Chabo C, Waget A, Delmee E, Cousin B, Sulpice T,
Chamontin B, Ferrieres J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM,
Alessi MC, Burcelin R: Metabolic endotoxemia initiates obesity and insulin
resistance. Diabetes 2007, 56:1761–1772.
7. Rabkin SW, Mathewson FA, Hsu PH: Relation of body weight to
development of ischemic heart disease in a cohort of young north
american men after a 26 year observation period: The manitoba study.
Am J Cardiol 1977, 39:452–458.
8. Hubert HB, Feinleib M, McNamara PM, Castelli WP: Obesity as an
independent risk factor for cardiovascular disease: A 26-year follow-up
of participants in the framingham heart study. Circulation 1983,
67:968–977.
9. Allison DB, Fontaine KR, Manson JE, Stevens J, VanItallie TB: Annual deaths
attributable to obesity in the united states. JAMA 1999, 282:1530–1538.
10. Grundy SM: Obesity, metabolic syndrome, and coronary atherosclerosis.
Circulation 2002, 105:2696–2698.
11. Eckel RH, Barouch WW, Ershow AG: Report of the national heart, lung, and
blood institute-national institute of diabetes and digestive and kidney
diseases working group on the pathophysiology of obesity-associated
cardiovascular disease. Circulation 2002, 105:2923–2928.
12. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R,
Hollenbeck A, Leitzmann MF: Overweight, obesity, and mortality in a
large prospective cohort of persons 50 to 71 years old. N Eng J Med 2006,
355:763–778.
13. van der Wal AC, Becker AE, van der Loos CM, Das PK: Site of intimal
rupture or erosion of thrombosed coronary atherosclerotic plaques is
characterized by an inflammatory process irrespective of the dominant
plaque morphology. Circulation 1994, 89:36–44.
14. Ross R: Atherosclerosis: an inflammatory disease. N Engl J Med 1999,
340:115–126.
15. Yip HK, Hung WC, Yang CH, Chen YH, Cheng CI, Chen SM, Yeh KH: Serum
concentrations of high-sensitivity c-reactive protein predict progressively
obstructive lesions rather than late restenosis in patients with unstable
angina undergoing coronary artery stenting. Circ J 2005, 69:1202–1207.
16. Orrico C, Pasquinelli G, Foroni L, Muscara D, Tazzari PL, Ricci F, Buzzi M, Baldi
E, Muccini N, Gargiulo M, Stella A: Dysfunctional vasa vasorum in diabetic
peripheral artery obstructive disease with critical lower limb ischaemia.
Eur J Vasc Endovasc Surg 2010, 40:365–374.
17. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig
G: Circulating endothelial progenitor cells and cardiovascular outcomes.
N Eng J Med 2005, 353:999–1007.
Tsai et al. Journal of Translational Medicine 2012, 10:137 Page 12 of 12
http://www.translational-medicine.com/content/10/1/13718. Lambiase PD, Edwards RJ, Anthopoulos P, Rahman S, Meng YG, Bucknall CA,
Redwood SR, Pearson JD, Marber MS: Circulating humoral factors and
endothelial progenitor cells in patients with differing coronary collateral
support. Circulation 2004, 109:2986–2992.
19. Valgimigli M, Rigolin GM, Fucili A, Porta MD, Soukhomovskaia O, Malagutti
P, Bugli AM, Bragotti LZ, Francolini G, Mauro E, Castoldi G, Ferrari R: CD34+
and endothelial progenitor cells in patients with various degrees of
congestive heart failure. Circulation 2004, 110:1209–1212.
20. Chironi G, Walch L, Pernollet MG, Gariepy J, Levenson J, Rendu F, Simon A:
Decreased number of circulating cd34 + kdr + cells in asymptomatic
subjects with preclinical atherosclerosis. Atherosclerosis 2007, 191:115–120.
21. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M,
Magner M, Isner JM: Bone marrow origin of endothelial progenitor cells
responsible for postnatal vasculogenesis in physiological and
pathological neovascularization. Circ Res 1999, 85:221–228.
22. Reyes M, Dudek A, Jahagirdar B: Origin of endothelial progenitors in
human postnatal bone marrow. J Clin Invest 2002, 109:337–346.
23. Van Heek M, Compton DS, France CF, Tedesco RP, Fawzi AB, Graziano MP,
Sybertz EJ, Strader CD, Davis HR Jr: Diet-induced obese mice develop
peripheral, but not central, resistance to leptin. J Clin Invest 1997,
99:385–390.
24. Yip HK, Chang LT, Chang WN, Lu CH, Liou CW, Lan MY, Liu JS, Youssef AA,
Chang HW: Level and value of circulating endothelial progenitor cells in
patients after acute ischemic stroke. Stroke 2008, 39:69–74.
25. Chang HW, Leu S, Sun CK, Hang CL, Youssef AA, Hsieh YK, Yang CH, Cheng
CI, Chen SM, Chen CJ, Chua S, Chang LT, Wu CJ, Yip HK: Level and value of
circulating endothelial progenitor cells in patients with acute myocardial
infarction undergoing primary coronary angioplasty: In vivo and in vitro
studies. Transl Res 2010, 156:251–263.
26. Sun CK, Chang LT, Sheu JJ, Chiang CH, Lee FY, Wu CJ, Chua S, Fu M, Yip HK:
Bone marrow-derived mononuclear cell therapy alleviates left ventricular
remodeling and improves heart function in rat-dilated cardiomyopathy.
Crit Care Med 2009, 37:1197–1205.
27. Yen CH, Lau YT: Vascular responses in male and female hypertensive rats
with hyperhomocysteinemia. Hypertension 2002, 40:322–328.
28. Meyers MR, Gokce N: Endothelial dysfunction in obesity: etiological role
in atherosclerosis. Curr Opin Endocrinol Diabetes Obes 2007, 14(5):365–369.
29. Campia U, Tesauro M, Cardillo C: Human obesity and endothelium-
dependent responsiveness. Br J Pharmacol 2012, 165:561–573.
30. Powell BD, Redfield MM, Bybee KA, Freeman WK, Rihal CS: Association of
obesity with left ventricular remodeling and diastolic dysfunction in
patients without coronary artery disease. Am J Cardiol 2006, 98:116–120.
31. Chadha DS, Gupta N, Goel K, Pandey RM, Kondal D, Ganjoo RK, Misra A:
Impact of obesity on the left ventricular functions and morphology of
healthy asian indians. Metab Syndr Relat Disord 2009, 7:151–158.
32. Gong HP, Tan HW, Fang NN, Song T, Li SH, Zhong M, Zhang W, Zhang Y:
Impaired left ventricular systolic and diastolic function in patients with
metabolic syndrome as assessed by strain and strain rate imaging.
Diabetes Res Clin Pract 2009, 83:300–307.
33. Barton M, Baretella O, Meyer MR: Obesity and risk of vascular disease:
importance of endothelium-dependent vasoconstriction. Br J Pharmacol
2012, 165:591–602.
34. Martins MA, Catta-Preta M, Mandarim-de-Lacerda CA, Aguila MB, Brunini TC,
Mendes-Ribeiro AC: High fat diets modulate nitric oxide biosynthesis and
antioxidant defence in red blood cells from c57bl/6 mice. Arch Biochem
Biophys 2010, 499:56–61.
35. Md Muhibur R, Zac V, Moorhead John F: Paradoxical increase in nitric
oxide synthase activity in hypercholesterolaemic rats with impaired
renal function and decreased activity of nitric oxide. Nephrol Dial
Transplant 2011, 16:262–268.
doi:10.1186/1479-5876-10-137
Cite this article as: Tsai et al.: Obesity suppresses circulating level and
function of endothelial progenitor cells and heart function. Journal of
Translational Medicine 2012 10:137.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
